China Biotech Services Holdings Limited (HKG:8037)

Hong Kong · Delayed Price · Currency is HKD

0.6900

-0.0200 (-2.90%)

Apr 20, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical and Health Related Services	36.83M	39.61M	193.07M	1.62B	607.78M
Medical and Health Related Services Growth	-7.02%	-79.48%	-88.10%	166.94%	-6.03%
Insurance Brokerage	37.57M	30.60M	18.16M	6.93M	7.92M
Insurance Brokerage Growth	22.78%	68.47%	161.98%	-12.48%	15.23%
BNCT	145.00K	-	-	-	-
Others	151.00K	141.00K	3.74M	13.52M	7.96M
Others Growth	7.09%	-96.23%	-72.34%	69.95%	512.00%
Intersegment Revenue	-1.20M	-1.06M	-5.57M	-72.54M	-
Pharmaceutical Products	-	1.22M	2.57M	281.21M	107.00K
Pharmaceutical Products Growth	-	-52.66%	-99.09%	262714.02%	-87.69%
Total	73.50M	70.51M	211.99M	1.85B	623.76M
Total Growth	4.25%	-66.74%	-88.55%	196.83%	-4.88%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Hong Kong, China	73.50M	-	-	-	-
Hong Kong	-	70.51M	211.97M	1.85B	623.76M
Hong Kong Growth	-	-66.74%	-88.55%	196.80%	-4.88%
PRC except Hong Kong	-	2.00K	13.00K	201.00K	-
PRC except Hong Kong Growth	-	-84.62%	-93.53%	-	-
Total	73.50M	70.51M	211.99M	1.85B	623.76M
Total Growth	4.25%	-66.74%	-88.55%	196.83%	-4.88%

Source: S&P Global Market Intelligence.